Allogene Therapeutics, Inc. · NASDAQ:ALLO

Tpg Gp A, LLC reported a 0% stake in Allogene Therapeutics, Inc. (Schedule 13D/A)

Event Sep 28, 2026 · Filed Sep 30, 2026

Tpg Gp A, LLC reported a 0% stake in Allogene Therapeutics, Inc., 0 shares, with active intent on Sep 28, 2026. Filed Sep 30, 2026 (Schedule 13D/A).

Stake
0%
Shares
0
Intent
Active
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
TPG GP A, LLC0%0
James G. Coulter0%0
Jon Winkelried0%0

Source

View original at SEC

Related